|1995: Current Mnagement took over and started manufacturing of Pharma intermediates
1997: Started manufacturing API's - launched its first drug Trimetazidine di hydrochloride
2000: Came withpublic offering of 25% Shares. Issue was oversubscribed by 3.85 times.
2000: Set up a R&D block to out Process synthesis for API's & Intermediates.
Jan 2005: Hon, Finance Minister of India Mr.P.Chidambaram put our company on the INDO NEXT at the BOMBAY STOCK EXCHANGE.
Jan 2005: Company was awarded with the ISO 9001-2000 accreditation by BVQI - UKAS & BVQI - ANAB
Mid 2005: Commissioning of a State of Art Formulation Unit for Oral Solid Dosages was started, Estimated cost of the project over 8 m USD
2006: Currently one of the leading manufacturers of Trimetazidine Di HCL , Ketoconazole and Pantoprazole Sodium in the country,besides catering to a widerange of drug intermedites for the Anti fungal & Anti Ulcer categories to name a few.
The services provided by the company are contract research and manufacturers, technology transfers and project consultancy.
- Company name has been changed from Sharon Pharma Chem Ltd to Sharon Bio-Medicine Ltd .
- Sharon Bio-Medicine Ltd has appointed Mr. Drunal Shah and Mr. Harish Palecanda, as Directors of the Company, w.e.f. December 31, 2009.